Open AccessImmune-related Thyroid Dysfunction (irTD) in Non-small Cell Lung Cancer (NSCLC) Correlates With Response and Survival
Author(s) -
Mario Giovanni Chilelli,
Carlo Signorelli,
Julio Rodrigo Giròn Berrìos,
Angelo Onorato,
Fabrizio Nelli,
M.A. Fabbri,
Francesca Primi,
Eleonora Marrucci,
Antonella Virtuoso,
Marta Schirripa,
Marco Mazzotta,
Enzo Maria Ruggeri
Publication year - 2022
Publication title -
cancer diagnosis and prognosis
Language(s) - English
Resource type - Journals
ISSN - 2732-7787
DOI - 10.21873/cdp.10076
Subject(s) - medicine , immunotherapy , immune system , oncology , lung cancer , thyroid dysfunction , retrospective cohort study , thyroid , non small cell lung cancer (nsclc) , thyroid cancer , gastroenterology , cancer , immunology , a549 cell
There is no clear information on the proportion of patients who need therapy for immune-related thyroid dysfunction (irTD) or who need to delay, omit, or discontinue immunotherapy. Furthermore, it is not well known whether irTD correlates with better outcomes or not.